Literature DB >> 7778884

Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.

J M Pfeffer1, T A Fischer, M A Pfeffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7778884     DOI： 10.1146/annurev.ph.57.030195.004105

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN： 0066-4278            Impact factor:   19.318


× No keyword cloud information.
  25 in total

1.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy.

Authors:  H Wakasaki; D Koya; F J Schoen; M R Jirousek; D K Ways; B D Hoit; R A Walsh; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Transforming growth factor (TGF)-β signaling in cardiac remodeling.

Authors:  Marcin Dobaczewski; Wei Chen; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2010-11-06       Impact factor: 5.000

3.  Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.

Authors:  E Mascareno; M Dhar; M A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 4.  Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery.

Authors:  Karolina K Marinescu; Nir Uriel; Douglas L Mann; Daniel Burkhoff
Journal:  Expert Rev Med Devices       Date:  2016-12-22       Impact factor: 3.166

5.  Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Authors:  Peiyong Zhai; Mitsutaka Yamamoto; Jonathan Galeotti; Jing Liu; Malthi Masurekar; Jill Thaisz; Keiichi Irie; Eric Holle; Xianzhong Yu; Sabina Kupershmidt; Dan M Roden; Thomas Wagner; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

Review 6.  Cardiac Fibrosis: The Fibroblast Awakens.

Authors:  Joshua G Travers; Fadia A Kamal; Jeffrey Robbins; Katherine E Yutzey; Burns C Blaxall
Journal:  Circ Res       Date:  2016-03-18       Impact factor: 17.367

7.  Targeted Delivery of VEGF after a Myocardial Infarction Reduces Collagen Deposition and Improves Cardiac Function.

Authors:  Jenna M Rosano; Rabee Cheheltani; Bin Wang; Hardik Vora; Mohammad F Kiani; Deborah L Crabbe
Journal:  Cardiovasc Eng Technol       Date:  2012-06       Impact factor: 2.495

8.  AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.

Authors:  Quang T Nguyen; Federico Colombo; Robert Clement; Hugues Gosselin; Jean-Lucien Rouleau; Angelino Calderone
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

9.  Extracellular matrix remodelling in myocardial hypertrophy and failure : focus on osteopontin.

Authors:  Pietro Francia; Arianna Uccellini; Alessandra Frattari; Anna Modestino; Agnese Ricotta; Cristina Balla; Ludovica Scialla; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

Review 10.  Regulation of cardiac angiotensin-converting enzyme and angiotensin AT1 receptor gene expression in Npr1 gene-disrupted mice.

Authors:  Kailash N Pandey; Elangovan Vellaichamy
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-10-16       Impact factor: 2.557
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.